Ọkwa njikere kampos bụ akwụkwọ ndụ akwụkwọ ndụ: Maka ọkwa UMMS kacha ọhụrụ, ozi na akụrụngwa, biko gaa na umassmed.edu/coronavirus
Dị ka akụkụ nke National Institutes of Health's Rapid Diagnostic Acceleration (RADx), nnyocha ogologo oge nke ndị ọrụ nyocha sitere na Mahadum Massachusetts Medical School dekọtara kwuru na ule PCR na ngwa ngwa antigen maka SARS-CoV-2 bara uru n'ịchọpụta. ọrịa Ọ na-adịkwa irè.Nye ọ dịkarịa ala ugboro abụọ n'izu.
Dị ka akwụkwọ akụkọ NIH si kwuo, ọ bụ ezie na a na-ewere ule PCR nke onwe ya dị ka ọkọlọtọ ọla edo, ọ na-enwe mmetụta karịa nyocha antigen, karịsịa na mmalite mmalite nke ọrịa, mana nsonaazụ na-egosi na mgbe a na-eme ya mgbe niile dị ka akụkụ nke mmemme nyocha, abụọ ahụ. ụzọ nnwale na-enwe mmetụta karịa.Mmetụta ahụ nwere ike iru 98%.Nke a bụ ozi ọma maka mmemme mgbochi buru ibu, n'ihi na nyocha antigen na ebe nlekọta ma ọ bụ n'ụlọ nwere ike inye nsonaazụ ozugbo na-enweghị ndenye ọgwụ ma dị ọnụ ala karịa nyocha ụlọ nyocha.
E bipụtara nchọpụta ahụ na "Journal of Diseases Diseases" na June 30. Ndị nchọpụta sitere na Mahadum Illinois na Urbana-Champaign, Johns Hopkins School of Medicine, na National Institute of Biomedical Imaging na Bioengineering bụ onye dere akwụkwọ a bụ: Prọfesọ Prọfesọ. nke ọgwụ Laura L. · Gibson (Laura L. Gibson);Alyssa N. Owens, Ph.D., Onye nhazi nyocha;John P. Broach, MD, MBA, MBA, Onye enyemaka Prọfesọ nke Ọgwụ Mberede;Bruce A. Barton, PhD, Population na Prọfesọ nke Quantitative Health Sciences;Peter Lazar, onye nrụpụta nchekwa data ngwa;na David D. McManus, MD, Richard M. Haidack Prọfesọ nke Medicine, oche nke Medicine na Prọfesọ.
Dr. Bruce Tromberg, Onye isi NIBIB, onye enyemaka NIH, kwuru, sị: “Ime nnwale ngwa ngwa antigen n'ụlọ ugboro abụọ ruo atọ n'izu bụ ụzọ dị ike ma dịkwa mma maka ndị mmadụ n'otu n'otu iji nyocha maka ọrịa COVID-19.“Site na ịmaliteghachi ụlọ akwụkwọ na azụmaahịa, ihe ize ndụ nke ibute ọrịa onwe onye nwere ike ịgbanwe kwa ụbọchị.Nnwale antigen na-aga n'ihu nwere ike inyere ndị mmadụ aka ịchịkwa ihe egwu a ma mee ngwa ngwa iji gbochie mgbasa nke nje a. "
Ndị ọrụ nyocha chịkọtara ụdị imi abụọ na ihe nlele mmiri maka ndị ọrụ na ụmụ akwụkwọ na-esonye n'oge mmemme nyocha COVID-19 na Mahadum Illinois na Urbana-Champaign maka ụbọchị iri na anọ.E zigara otu n'ime imi imi nke onye ọ bụla so na ụlọ nyocha Mahadum Johns Hopkins ka ọ hụ uto nje na-adị ndụ na ọdịbendị na iji tụọ oge oge isiokwu ahụ nwere ike ibunye ndị ọzọ ọrịa ahụ.
Ndị nyocha ahụ tụlere ụzọ nchọpụta COVID-19 atọ: nnwale PCR mmiri, nnwale PCR imi, na nlele imi ngwa ngwa antigen.Ha gbakọrọ uche nke usoro nnwale ọ bụla iji chọpụta SARS-CoV-2 wee tụọ ọnụnọ nje dị ndụ n'ime izu abụọ nke ọrịa.
Mgbe ndị nyocha ahụ gbakọrọ nyocha ule dabere na uda ule kwa ụbọchị atọ, ha kwuru na ma ha jiri ule antigen ngwa ngwa ma ọ bụ ule PCR, mmetụta nke ịchọpụta ọrịa dị elu karịa 98%.Mgbe ha na-enyocha naanị ugboro nchoputa otu ugboro n'izu, nghọta nke nchọpụta PCR maka imi na mmiri ka dị elu, ihe dịka 98%, mana mmetụta nke nchọpụta antigen gbadara ruo 80%.
"Ihe ịma aka dị n'ịsụgharị PCR ma ọ bụ nsonaazụ ule antigen bụ na nyocha dị mma nwere ike ọ gaghị egosi ọnụnọ nke ọrịa na-efe efe (dị ala akọwapụtara) ma ọ bụ na ọ gaghị achọpụta nje dị ndụ na nlele (mmetụta dị ala), n'otu n'otu," ka onye isi otu Dr. Gibson.RADx Tech Clinical Research isi.
"Ihe pụrụ iche nke nyocha a bụ na anyị jikọtara PCR na nchọpụta antigen na omenala nje dị ka akara na-efe efe.Nchọpụta nyocha a na-ekpughe ụzọ kachasị mma isi jiri ụdị ule ọ bụla, ma belata ihe egwu nke COVID-19 a na-enyo enyo Onye ọrịa ahụ na-akọwa mmetụta nke ihe ịma aka nke nsonaazụ ha. "
Dr. Nathaniel Hafer, osote prọfesọ nke ọgwụ molecular na onye isi nyocha nke RADx Tech Study Logistics Core, kwuru, sị: “Dị ka ihe atụ nke mmetụta ọrụ anyị nwere, data anyị na-anakọta na-enye aka inye CDC ozi gbasara ọnụ ọgụgụ dị iche iche.”
Dr. Hafer rụtụrụ aka na isi ọrụ nke UMass School of Medicine na nhazi, mmejuputa na nyocha nke ule uche a.O toro ndị otu nyocha nke Mahadum Massachusetts Medical School nke Dr. Broach na-edu, gụnyere onye isi ọrụ Gul Nowshad na onye nyocha nyocha Bernadette Shaw-maka ọrụ ha na-elele anya ndị sonyere na ọmụmụ ihe na ụlọ obibi Otu ọrụ dị mkpa na Mahadum nke Illinois.
Akụkọ metụtara ya sitere na UMassMed News: N'oge nleta Congress na ogige NIH, e mesiri atụmatụ RADx ike.Ụlọ akwụkwọ ahụike UMass na-enyere aka iduzi NIH RADx iji mee ka teknụzụ nnwale COVID ọhụrụ dịkwuo elu.Akụkọ akụkọ: UMass Medical School na-enweta onyinye NIH $ 100 nde iji kwalite nnwale COVID-19 ngwa ngwa na ịnweta.
Questions or comments? Email: UMMSCommunications@umassmed.edu Tel: 508-856-2000 • 508-856-3797 (fax)
Oge nzipu: Jul-14-2021